Loading organizations...
Loading organizations...
Innovative drug research and development service provider.
Baoling Bio has raised $85.9M across 1 funding round.
Baoling Bio has raised $85.9M in total across 1 funding round.
Baoling Bio has raised $85.9M in total across 1 funding round.
Baoling Bio's investors include Qiming Venture Partners, TrueLight Capital, 5Y Capital, Guosheng Capital.
Baoling Bio has raised $85.9M across 1 funding round. Most recently, it raised $85.9M Series C in January 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 16, 2026 | $85.9M Series C | Qiming Venture Partners, TrueLight Capital | 5Y Capital, Guosheng Capital |